Cargando…

The Landscape of Tumor-Infiltrating Immune Cells in Feline Mammary Carcinoma: Pathological and Clinical Implications

Feline mammary carcinoma (FMC) shares key molecular and clinicopathological features with human breast cancer. We have herein studied the inflammatory infiltrate of FMC in order to uncover potential therapeutic targets and prognostic markers. To this end, the expression of different markers (CD3, CD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nascimento, Catarina, Gameiro, Andreia, Correia, Jorge, Ferreira, João, Ferreira, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406662/ https://www.ncbi.nlm.nih.gov/pubmed/36010653 http://dx.doi.org/10.3390/cells11162578

Ejemplares similares

Diagnostic Value of VEGF-A, VEGFR-1 and VEGFR-2 in Feline Mammary Carcinoma
por: Nascimento, Catarina, et al.
Publicado: (2021)

VISTA Is a Diagnostic Biomarker and Immunotherapy Target of Aggressive Feline Mammary Carcinoma Subtypes
por: Gameiro, Andreia, et al.
Publicado: (2021)

HER2-Targeted Immunotherapy and Combined Protocols Showed Promising Antiproliferative Effects in Feline Mammary Carcinoma Cell-Based Models
por: Gameiro, Andreia, et al.
Publicado: (2021)

Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes
por: Gameiro, Andreia, et al.
Publicado: (2021)

TIM-3 Is a Potential Immune Checkpoint Target in Cats with Mammary Carcinoma
por: Valente, Sofia, et al.
Publicado: (2023)

Emerging Biomarkers and Targeted Therapies in Feline Mammary Carcinoma
por: Gameiro, Andreia, et al.
Publicado: (2021)

Serum PD-1/PD-L1 Levels, Tumor Expression and PD-L1 Somatic Mutations in HER2-Positive and Triple Negative Normal-Like Feline Mammary Carcinoma Subtypes
por: Nascimento, Catarina, et al.
Publicado: (2020)

Histone Deacetylase Inhibitors and Microtubule Inhibitors Induce Apoptosis in Feline Luminal Mammary Carcinoma Cells
por: Almeida, Filipe, et al.
Publicado: (2021)

Tyrosine Kinase Inhibitors Are Promising Therapeutic Tools for Cats with HER2-Positive Mammary Carcinoma
por: Gameiro, Andreia, et al.
Publicado: (2021)

HER2-positive feline mammary carcinoma
por: Marques, Cláudia, et al.
Publicado: (2016)

Gene expression association study in feline mammary carcinomas
por: Ferreira, Daniela, et al.
Publicado: (2019)

Anaplastic Mammary Carcinoma in Cat
por: Soares, Maria, et al.
Publicado: (2021)

CXCR4 and its ligand CXCL12 display opposite expression profiles in feline mammary metastatic disease, with the exception of HER2-overexpressing tumors
por: Marques, Cláudia S., et al.
Publicado: (2018)

Clinical Relevance of the serum CTLA-4 in Cats with Mammary Carcinoma
por: Urbano, Ana Catarina, et al.
Publicado: (2020)

CXCL12-CXCR4 axis in feline mammary carcinoma
por: Ferreira, Fernando
Publicado: (2017)

Assessment of ERBB2 and TOP2α gene status and expression profile in feline mammary tumors: findings and guidelines
por: Ferreira, Daniela, et al.
Publicado: (2019)

Serum SDF-1 levels are a reliable diagnostic marker of feline mammary carcinoma, discriminating HER2-overexpressing tumors from other subtypes
por: Marques, Cláudia S., et al.
Publicado: (2017)

fHER2, PR, ER, Ki-67 and Cytokeratin 5/6 Expression in Benign Feline Mammary Lesions
por: Soares, Maria, et al.
Publicado: (2022)

Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas
por: Figueira, Ana Catarina, et al.
Publicado: (2014)

Pathological Features and Molecular Phenotype of MMTV Like-Positive Feline Mammary Carcinomas
por: Parisi, Francesca, et al.
Publicado: (2021)

Serum HER2 levels are increased in cats with mammary carcinomas and predict tissue HER2 status
por: Soares, Maria, et al.
Publicado: (2016)

Immune Infiltration Landscape in Lung Squamous Cell Carcinoma Implications
por: Zhao, Jungang, et al.
Publicado: (2020)

P-cadherin expression in feline mammary tissues
por: Figueira, A Catarina, et al.
Publicado: (2010)

P-Cadherin Expression in Feline Mammary Tissues
por: Figueira, Ana Catarina, et al.
Publicado: (2012)

Immune Infiltration Landscape in Clear Cell Renal Cell Carcinoma Implications
por: Wang, Yongfeng, et al.
Publicado: (2021)

The Heterogeneity of Immune Cell Infiltration Landscape and Its Immunotherapeutic Implications in Hepatocellular Carcinoma
por: Guo, Yuanyuan, et al.
Publicado: (2022)

The implication of autoantibodies in early diagnosis and monitoring of plasmonic photothermal therapy in the treatment of feline mammary carcinoma
por: El-Rasikh, Asmaa M., et al.
Publicado: (2021)

Immunohistochemical Expression of p62 in Feline Mammary Carcinoma and Non-Neoplastic Mammary Tissue
por: Magi, Gian Enrico, et al.
Publicado: (2022)

Analysis of Copy-Number Variations and Feline Mammary Carcinoma Survival
por: Granados-Soler, José Luis, et al.
Publicado: (2020)

Expression of HIF-1α and VEGF in feline mammary gland carcinomas: association with pathological characteristics and clinical outcomes
por: Chen, Bo, et al.
Publicado: (2020)

Four cases of cell cannibalism in highly malignant feline and canine tumors
por: Ferreira, Fernando Costa, et al.
Publicado: (2015)

Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 2: Feline Mammary Carcinomas
por: Chocteau, Florian, et al.
Publicado: (2019)

Serum Amyloid A Promotes Invasion of Feline Mammary Carcinoma Cells
por: TAMAMOTO, Takashi, et al.
Publicado: (2014)

Intratumoral collagen signatures predict clinical outcomes in feline mammary carcinoma
por: Rosen, Suzanne, et al.
Publicado: (2020)

Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways
por: Granados-Soler, José Luis, et al.
Publicado: (2022)

Tumor Infiltrating Lymphocytes in Pet Rabbit Mammary Carcinomas: A Study with Relevance to Comparative Pathology
por: Schöniger, Sandra, et al.
Publicado: (2020)

Lymphatic vessels assessment in feline mammary tumours
por: Sarli, Giuseppe, et al.
Publicado: (2007)

Characterisation of macrophages infiltrating human mammary carcinomas.
por: Steele, R. J., et al.
Publicado: (1985)

Anti-tumor effect of bevacizumab on a xenograft model of feline mammary carcinoma
por: MICHISHITA, Masaki, et al.
Publicado: (2015)

Publisher Correction: Analysis of Copy-Number Variations and Feline Mammary Carcinoma Survival
por: Granados-Soler, José Luis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s882pr5cfp4ode2e8gipkr1s8l